វេទិកាឱសថស្ថានសិង្ហបុរីចាប់ផ្តើមផ្តល់ប្រាក់ 27 លានដុល្លារនៅក្នុងជុំផ្តល់មូលនិធិដែលគាំទ្រដោយ Bill Gates

Pharmacy app SwipeRx raised $27 million in a Series B funding round led by Indonesia’s MDI Ventures. Other backers included the វិក័យប័ត្រ & មេលីនដាហ្គេត។ Foundation, Johnson & Johnson Impact Ventures, Pennsylvania-based Susquehanna International Group and other existing investors.

SwipeRx’s app is designed for Southeast Asia’s pharmacy professionals, which allows them to connect and purchase medicine through the platform’s B2B commerce tool, as well as receive industry news and information.

The latest funds will be used to further accelerate its growth across Southeast Asia with a focus on Indonesia, according to SwipeRx’s សេចក្តី​ប្រកាស​ព័ត៌មាន.

Headquartered in Singapore, the startup was founded in 2012 by Farouk Meralli, who previously worked as a consultant at Johnson & Johnson and Pfizer.

“This round of funding reaffirms our commitment to disrupt this deeply fragmented industry while improving public health by supporting the pharmacy channel,” Meralli, who is also CEO, said in the press release.

SwipeRx has partnered with healthcare organizations such as AstraZeneca, Clinton Health Access Initiative, Stanford University, University of Oxford and more, with over 235,000 pharmacy professionals using its platform, according to its គេហទំព័រ. It has offices in Singapore, Indonesia, Philippines, Thailand, Vietnam, Malaysia and Cambodia.

The startup—formerly known as mClinica—last raised $6.3 million in its ស៊េរីក។ funding round in 2017.